Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2011-01-27Clinical Trial Update: Treating Hypertension With Breath Control [NA]
This clinical trial update reports a study in Malaysia evaluating breath control as a potential treatment for hypertension; no results or cu…
-
FDA approval · 2011-01-26FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for furosemide from Hikma Pharmaceuticals USA Inc., updating or adding to the product's labeling and…
-
FDA approval · 2011-01-26FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for furosemide, a generic diuretic, under the existing ANDA.
-
FDA approval · 2011-01-26FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for furosemide filed by Hikma Pharmaceuticals USA Inc., updating the approved generic product un…
-
FDA approval · 2011-01-26FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for furosemide from Hikma Pharmaceuticals USA Inc., authorizing a change to the NDA (such as lab…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-01-26Clinical Trial Update: A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients [Phase 4]
A Phase 4 study evaluated the efficacy and safety of Nebivolol monotherapy in Hispanic adults with hypertension; the trial completed and res…
-
FDA approval · 2011-01-26FDA Approved: CLONIDINE HYDROCHLORIDE — Original Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved Hikma Pharmaceuticals USA Inc.'s clonidine hydrochloride generic under ANDA200300, authorizing its marketing as a generic a…
-
FDA approval · 2011-01-25FDA Approved: COREG CR — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for COREG CR (carvedilol phosphate) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2011-01-25FDA Approved: COREG — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for COREG (carvedilol) submitted by Waylis Therapeutics LLC. The action represents a label-related c…
-
CLINICAL_TRIALS trial_result · 2011-01-21Clinical Trial Update: Efficacy and Safety of the Combination Aliskiren (300 mg) and Hydrochlorothiazide (25mg) to Aliskiren (300mg) Monotherapy in Patients With Staged II Hypertension [Phase 3]
Phase 3 trial evaluating efficacy and safety of aliskiren 300 mg plus hydrochlorothiazide 25 mg versus aliskiren 300 mg monotherapy in patie…
-
CLINICAL_TRIALS trial_result · 2011-01-21Clinical Trial Update: Blood Pressure Lowering of Aliskiren HCTZ Compared to HCTZ in Stage 2 Systolic Hypertension in Older Population [Phase 4]
Phase 4 trial comparing blood pressure reduction with aliskiren/HCTZ versus HCTZ alone in older adults with stage 2 systolic hypertension; r…
-
CLINICAL_TRIALS trial_result · 2011-01-21Clinical Trial Update: Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg [Phase 4]
A Phase 4 study evaluating the effect of the fixed-dose combination of amlodipine and valsartan on central aortic blood pressure in patients…
-
CLINICAL_TRIALS trial_result · 2011-01-21Clinical Trial Update: Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension [Phase 4]
A Phase 4 trial compared aliskiren plus amlodipine versus amlodipine alone in African American patients with stage 2 hypertension to assess …
-
FDA approval · 2011-01-20FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for diltiazem hydrochloride (Apotex Corp.), a generic calcium channel blocker. The approval covers t…
-
CLINICAL_TRIALS trial_result · 2011-01-19Clinical Trial Update: CKD-828(80/2.5mg) Pharmacokinetic Study [Phase 1]
A Phase 1 pharmacokinetic study of CKD-828 (80/2.5 mg) has completed. The study targeted hypertension.
-
CLINICAL_TRIALS trial_result · 2011-01-19Clinical Trial Update: The Effect of a Complementary Multi Disciplinary Program on Blood Pressure in Hypertensive Patients [Phase 3]
Phase 3 clinical trial evaluating a complementary multi-disciplinary program for reducing blood pressure in hypertensive patients has comple…
-
FDA approval · 2011-01-18FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Lisinopril and Hydrochlorothiazide from Aurobindo Pharma Limited. The action represents an appro…
-
CLINICAL_TRIALS research · 2011-01-17Clinical Trial Update: Therapeutic Lifestyle Modifications to Reduce Burden of Chronic Disease [NA]
This document reports the completion of a clinical trial evaluating therapeutic lifestyle modifications to reduce the burden of chronic dise…
-
FDA approval · 2011-01-12FDA Approved: RAMIPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for RAMIPRIL (ramipril) from Hikma Pharmaceuticals USA Inc., allowing a generic ramipril product to …
-
CLINICAL_TRIALS trial_result · 2011-01-12Clinical Trial Update: Effect of the Angiotensin II Receptor Antagonist Irbesartan on Biochemical and Functional Markers of Endothelial Dysfunction in Patients With Hypertension [Phase 4]
Phase 4 trial evaluating the impact of irbesartan on biochemical and functional markers of endothelial dysfunction in hypertension patients;…
-
CLINICAL_TRIALS trial_result · 2011-01-12Clinical Trial Update: Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic Hypertension [Phase 4]
Phase 4 trial comparing aliskiren plus hydrochlorothiazide versus aliskiren alone in patients with metabolic syndrome and stage 2 systolic h…
-
CLINICAL_TRIALS trial_result · 2011-01-12Clinical Trial Update: Blood Pressure Lowering of Aliskiren Hydrochlorothiazide (HCTZ) Versus Amlodipine in Stage 2 Hypertension in African Americans [Phase 4]
Phase 4 trial comparing a fixed-dose aliskiren/hydrochlorothiazide combination with amlodipine for blood pressure reduction in stage 2 hyper…
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood Pressure [Phase 3]
Phase 3 trial results assess the long-term safety of the aliskiren/amlodipine combination in patients with hypertension.
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Ambulatory Blood Pressure Monitoring in Hypertension [NA]
The clinical trial update indicates that the ambulatory blood pressure monitoring study for hypertension conducted at Arkansas Children's Ho…
-
FDA approval · 2011-01-06FDA Approved: COREG — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for COREG (carvedilol) submitted by Waylis Therapeutics LLC.